DOLBY LABORATORIES, INC.

Consensus Dolby Laboratories, Inc.

Stocks

DLB

US25659T1079

Software

Market Closed - NYSE 00:00:03 22/09/2026 +04			5-day change	1st Jan Change
57.33 ^USD	-0.56%		-11.09%	-10.73%

09-10	Dolby Laboratories Expands Dolby OptiView Platform With New Capabilities At IBC 2026	CI
08-27	Dolby Laboratories, Inc. Announces Management Changes, Effective August 27, 2026	CI

Evolution of the Average Target: Dolby Laboratories, Inc.

Evolution of the Target Price: Dolby Laboratories, Inc.

Changes in Analyst Recommendations: Dolby Laboratories, Inc.

3d3feeacbf0c5675d8507dac0097ce8._jqJgN4DYUq6yr15c8Vg7GxbWA50BbgdgPJjHpXR3wg.pgPAtLNbVgyNgos2GpU3plwebGIecud467hSVv2H7GqGU-r4gW8oPYqfhQ~5df284eb4dc5c27b3b8b7f9e02c7e4be

Analysts' recommendations: Dolby Laboratories, Inc.

11-19	Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating	MT
05/09/25	Baird Initiates Dolby Laboratories at Neutral With $74 Price Target	MT
15/08/25	Dolby Laboratories' Immersive Media Innovation, Strategic Partnerships to Drive Long-Term Growth, Tigress Financial Partners Says	MT
15/08/25	Tigress Adjusts Price Target on Dolby Laboratories to $114 From $112, Maintains Buy Rating	MT
03/06/24	Barrington Upgrades Dolby Laboratories to Outperform From Market Perform, Price Target is $100	MT
04/08/23	Rosenblatt Adjusts Price Target on Dolby Laboratories to $98 From $93, Maintains Buy Rating	MT
03/02/23	Rosenblatt Adjusts Price Target on Dolby Laboratories to $90 From $85, Maintains Buy Rating	MT
18/11/22	Barrington Downgrades Dolby Laboratories to Market Perform From Outperform as Economic Challenges Results in Lower Volumes	MT
18/11/22	Barrington Downgrades Dolby Laboratories to Market Perform From Outperform	MT
07/11/22	Rosenblatt Adjusts Price Target on Dolby Laboratories to $85 From $90, Maintains Buy Rating	MT
14/10/22	Tigress Financial Cuts Dolby Laboratories' Price Target to $116 From $128 'on Near-Term Valuation Rerating;' Buy Rating Kept	MT
24/05/22	Rosenblatt Starts Dolby Laboratories at Buy With $90 Price Target	MT
12/05/22	Barrington Research Lowers Price Target for Dolby Laboratories to $90 From $115, Maintains Outperform Rating	MT
02/08/21	Dolby Laboratories : Barrington Upgrades Dolby Laboratories to Outperform From Market Perform "as New Initiatives Supplement Progress", Sets $115 Price Target	MT
29/01/21	Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $89 From $79, Keeps Neutral Rating	MT
04/01/21	Dolby Laboratories : Barrington Research Downgrades Dolby Laboratories to Market Perform From Outperform	MT
13/11/20	Dolby Laboratories : JP Morgan Adjusts Price Target for Dolby Laboratories to $90 From $78, Maintains Overweight Rating	MT
13/11/20	Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $79 from $73, Keeps Neutral Rating	MT
13/11/20	Dolby Laboratories : Barrington Research Adjusts PT on Dolby Laboratories to $95 From $83, Citing 'Meaningful Positive Momentum;' Outperform Rating Kept	MT

More recommendations

System Software

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DOLBY LABORATORIES, INC.					+37.03%
	ZSCALER, INC.					+5.85%
	KLARNA GROUP PLC					+44.69%
	MONDAY.COM LTD.					+28.04%
	TRAFFIC CONTROL TECHNOLOGY CO., LTD.			-	-	+55.38%
	Average					+34.20%
	Weighted average by Cap.					+15.97%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

4

Last Close Price

57.65USD

Average target price

79.00USD

Spread / Average Target

+37.03%

High Price Target

90.00USD

Spread / Highest target

+56.11%

Low Price Target

62.00USD

Spread / Lowest Target

+7.55%

Analyst Consensus Detail

Consensus revision (last 18 months)

Ratings

Trader

Investor

-

Global

-

Quality

-

ESG MSCI

A

Stock Market
Stocks
DLB Stock
Consensus Dolby Laboratories, Inc.

-40%: Exceptional extension

SEIZE THE OFFER!